AI assistant
Schrodinger, Inc. — Director's Dealing 2020
Feb 5, 2020
31925_dirs_2020-02-05_962ff9e9-3a73-46a3-aa46-7c635dc19012.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Schrodinger, Inc. (SDGR)
CIK: 0001490978
Period of Report: 2020-02-05
Reporting Person: BILL & MELINDA GATES FOUNDATION TRUST (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series B preferred stock | $ | Common Stock (3942041) | Direct | ||
| Series C preferred stock | $ | Common Stock (6319743) | Direct | ||
| Series D preferred stock | $ | Common Stock (4808612) | Direct | ||
| Series E preferred stock | $ | Common Stock (4487226) | Direct |
Footnotes
F1: All shares of Series B preferred stock, $0.01 par value per share, have no expiration date and will automatically convert into the Issuer's common stock on a 7.47534-for-1 basis upon the closing of the Issuer's initial public offering ("IPO"), unless voluntarily exchanged at the discretion of Bill & Melinda Gates Foundation Trust (the "Trust") into the Issuer's limited common stock on a 7.47534-for-1 basis. The Trust expects to exchange all of its Series B preferred stock into the Issuer's limited common stock upon the closing of the Issuer's IPO.
F2: All shares of Series C preferred stock, $0.01 par value per share, have no expiration date and will automatically convert into the Issuer's common stock on a 7.47534-for-1 basis upon the closing of the Issuer's IPO, unless voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis. The Trust expects to exchange all of its Series C preferred stock into the Issuer's limited common stock upon the closing of the Issuer's IPO.
F3: All shares of Series D preferred stock, $0.01 par value per share, have no expiration date and will automatically convert into the Issuer's common stock on a 7.47534-for-1 basis upon the closing of the Issuer's IPO, unless voluntarily exchanged at the discretion of the Trust into the Issuer's limited common stock on a 7.47534-for-1 basis. The Trust expects its Series D preferred stock to be exchanged into 2,902,409 shares of the Issuer's limited common stock and 1,906,203 shares of the Issuer's common stock upon the closing of the Issuer's IPO.
F4: All shares of Series E preferred stock, $0.01 par value per share, have no expiration date and will automatically convert into the Issuer's common stock on a 7.47534-for-1 basis upon the closing of the Issuer's IPO.